. (CPXX)
$30.24 - (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
. (CPXX)
$30.24
- (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$30.24
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$30.24
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Kovner Bruce | See Remarks Section | Jul 12, 2016 | Option Exercise | $30.25 | 564,222 | 17,067,716 | 0 | Jul 12, 2016, 05:07 PM |
| Kovner Bruce | See Remarks Section | Jul 12, 2016 | Option Exercise | $30.25 | 1,591,750 | 48,150,438 | 0 | Jul 12, 2016, 05:07 PM |
| Morenstein Scott D | Director | Jul 12, 2016 | Option Exercise | $30.25 | 6,277 | 189,879 | 0 | Jul 12, 2016, 05:04 PM |
| Morenstein Scott D | Director | Jul 12, 2016 | Option Exercise | $30.25 | 1,039,109 | 31,433,047 | 0 | Jul 12, 2016, 05:04 PM |
| Valence Life Sciences GP II LLC | Member of a 10% Group | Jul 12, 2016 | Option Exercise | $30.25 | 143,986 | 4,355,577 | 0 | Jul 12, 2016, 05:00 PM |
| Valence Life Sciences GP II LLC | Member of a 10% Group | Jul 12, 2016 | Option Exercise | $30.25 | 1,039,109 | 31,433,047 | 0 | Jul 12, 2016, 05:00 PM |
| Powell Fred M | VP and Chief Financial Officer | Jul 12, 2016 | Option Exercise | $30.25 | 156,064 | 4,720,936 | 0 | Jul 12, 2016, 04:24 PM |
| Jackson Scott Thomas | Chief Executive Officer | Jul 12, 2016 | Option Exercise | $30.25 | 301,518 | 9,120,920 | 0 | Jul 12, 2016, 04:21 PM |
| Mayer Lawrence David | See Remarks | Jul 12, 2016 | Option Exercise | $30.25 | 107,515 | 3,252,329 | 0 | Jul 12, 2016, 04:21 PM |
| Mayer Lawrence David | See Remarks | Jul 12, 2016 | Option Exercise | $30.25 | 3,631 | 109,838 | 0 | Jul 12, 2016, 04:21 PM |
| Mayer Lawrence David | See Remarks | Jul 12, 2016 | Option Exercise | $30.25 | 7,468 | 225,907 | 0 | Jul 12, 2016, 04:21 PM |
| DOUGHERTY MICHAEL R | Executive Chairman | Jul 12, 2016 | Option Exercise | $30.25 | 20,000 | 605,000 | 0 | Jul 12, 2016, 04:18 PM |
| Jackson Scott Thomas | Chief Executive Officer | Jul 07, 2016 | Option Exercise | $2.84 | 251,475 | 714,147 | 301,518 | Jul 07, 2016, 06:02 PM |
| Powell Fred M | VP and Chief Financial Officer | Jul 06, 2016 | Option Exercise | $3.12 | 71,887 | 224,000 | 156,064 | Jul 07, 2016, 06:02 PM |
| Powell Fred M | See Remarks | Jun 23, 2016 | Option Exercise | $30.15 | 2,491 | 75,104 | 85,842 | Jun 27, 2016, 09:39 PM |
| Powell Fred M | See Remarks | Jun 23, 2016 | Option Exercise | $1.32 | 56,875 | 75,075 | 88,333 | Jun 27, 2016, 09:39 PM |
| Mayer Lawrence David | President and Head of Research | Mar 15, 2016 | Option Exercise | $8.94 | 12,081 | 108,004 | 107,515 | Mar 17, 2016, 04:59 PM |
| Mayer Lawrence David | President and Head of Research | Mar 15, 2016 | Option Exercise | $2.25 | 48,002 | 108,005 | 119,596 | Mar 17, 2016, 04:59 PM |
| Morenstein Scott D | Director | Dec 03, 2015 | Buy | $1.87 | 5,000 | 9,325 | 6,277 | Dec 07, 2015, 10:54 AM |
| Jackson Scott Thomas | Chief Executive Officer | Oct 06, 2015 | Buy | $1.74 | 14,450 | 25,143 | 50,043 | Oct 07, 2015, 09:21 AM |
| Powell Fred M | VP and Chief Financial Officer | Oct 05, 2015 | Buy | $1.78 | 13,700 | 24,386 | 31,458 | Oct 05, 2015, 04:05 PM |
| Valence Life Sciences GP II LLC | Member of a 10% Group | Oct 01, 2015 | Buy | $1.64 | 2,000 | 3,280 | 171,986 | Oct 02, 2015, 08:02 PM |
| Valence Life Sciences GP II LLC | Member of a 10% Group | Sep 30, 2015 | Buy | $1.64 | 10,200 | 16,774 | 169,986 | Oct 02, 2015, 08:02 PM |
| Mayer Lawrence David | See Remarks | May 14, 2015 | Option Exercise | $2.25 | 55,000 | 123,750 | 71,594 | May 28, 2015, 04:01 PM |
| DOUGHERTY MICHAEL R | Director | Nov 18, 2014 | Buy | $2.15 | 20,000 | 42,940 | 20,000 | Nov 20, 2014, 04:06 PM |
| Powell Fred M | Chief Financial Officer | Nov 18, 2014 | Buy | $2.20 | 6,000 | 13,200 | 11,000 | Nov 18, 2014, 04:01 PM |
| Jackson Scott Thomas | Chief Executive Officer | Nov 18, 2014 | Buy | $2.20 | 10,000 | 22,000 | 13,000 | Nov 18, 2014, 04:00 PM |
| Powell Fred M | Chief Financial Officer | May 15, 2014 | Buy | $2.50 | 2,500 | 6,240 | 5,000 | May 16, 2014, 12:03 PM |
| Powell Fred M | VP and CFO | Dec 17, 2013 | Buy | $3.50 | 2,500 | 8,750 | 2,500 | Dec 17, 2013, 04:10 PM |
| Jackson Scott Thomas | Chief Executive Officer | Dec 17, 2013 | Buy | $3.50 | 3,000 | 10,490 | 3,000 | Dec 17, 2013, 04:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Kovner Bruce | See Remarks Section | 07/12/2016 | 17,067,716 |
| Kovner Bruce | See Remarks Section | 07/12/2016 | 48,150,438 |
| Morenstein Scott D | Director | 07/12/2016 | 189,879 |
| Morenstein Scott D | Director | 07/12/2016 | 31,433,047 |
| Valence Life Sciences GP II LLC | Member of a 10% Group | 07/12/2016 | 4,355,577 |
| Valence Life Sciences GP II LLC | Member of a 10% Group | 07/12/2016 | 31,433,047 |
| Powell Fred M | VP and Chief Financial Officer | 07/12/2016 | 4,720,936 |
| Jackson Scott Thomas | Chief Executive Officer | 07/12/2016 | 9,120,920 |
| Mayer Lawrence David | See Remarks | 07/12/2016 | 3,252,329 |
| Mayer Lawrence David | See Remarks | 07/12/2016 | 109,838 |
| Mayer Lawrence David | See Remarks | 07/12/2016 | 225,907 |
| DOUGHERTY MICHAEL R | Executive Chairman | 07/12/2016 | 605,000 |
| Jackson Scott Thomas | Chief Executive Officer | 07/07/2016 | 714,147 |
| Powell Fred M | VP and Chief Financial Officer | 07/06/2016 | 224,000 |
| Powell Fred M | See Remarks | 06/23/2016 | 75,104 |
| Powell Fred M | See Remarks | 06/23/2016 | 75,075 |
| Mayer Lawrence David | President and Head of Research | 03/15/2016 | 108,004 |
| Mayer Lawrence David | President and Head of Research | 03/15/2016 | 108,005 |
| Morenstein Scott D | Director | 12/03/2015 | 9,325 |
| Jackson Scott Thomas | Chief Executive Officer | 10/06/2015 | 25,143 |
| Powell Fred M | VP and Chief Financial Officer | 10/05/2015 | 24,386 |
| Valence Life Sciences GP II LLC | Member of a 10% Group | 10/01/2015 | 3,280 |
| Valence Life Sciences GP II LLC | Member of a 10% Group | 09/30/2015 | 16,774 |
| Mayer Lawrence David | See Remarks | 05/14/2015 | 123,750 |
| DOUGHERTY MICHAEL R | Director | 11/18/2014 | 42,940 |
| Powell Fred M | Chief Financial Officer | 11/18/2014 | 13,200 |
| Jackson Scott Thomas | Chief Executive Officer | 11/18/2014 | 22,000 |
| Powell Fred M | Chief Financial Officer | 05/15/2014 | 6,240 |
| Powell Fred M | VP and CFO | 12/17/2013 | 8,750 |
| Jackson Scott Thomas | Chief Executive Officer | 12/17/2013 | 10,490 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...